BioSpace News Archive

Appointed Gregory Berk, M.D. to the Position of Chief Medical Officer and Jeffery Miller, M.D. to the Position of Consulting Chief Scientific Officer

Texas Children’s Pediatrics, the nation’s largest pediatric primary care network, announced its 12th location in Austin, Texas and the surrounding areas.

Orion Biotech Opportunities Corp. (the “Company”) today announced the closing of its initial public offering (“IPO”) of 20,000,000 units at a price of $10.00 per unit, resulting in total gross proceeds of $200,000,000

Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks andimproved lung function in children

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the presentation of detailed results from the Phase 3 pivotal trial showing REGEN–COV™ (casirivimab with imdevimab) significantly reduced the risk of hospitalization or death, shortened symptom duration and reduced viral load in non-hospitalized patients (outpatients) with COVID-19.

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chairperson and Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the William Blair’s 41st Annual Growth Stock Conference on Wednesday, May 26, 2021,

Dynatronics Corporation, a leading manufacturer of athletic training, physical therapy, and rehabilitation products, announced that it has closed on its purchase and sale agreement with Maple Leaf Realco VII, LLC for a purchase price of $1.75 million USD, effective May 13, 2021.

Sandoz, a global leader in biosimilar and generic medicines, today announced that the US Supreme Court has denied its petition to review the Federal Circuit’s July 2020 decision concerning the Sandoz biosimilar Erelzi® (etanercept-szzs) for reference medicine Enbrel®* (etanercept).

Leading PT provider in the Northeast grows outpatient offerings through on-demand, delivery PT service

Award from The Joint Commission, Kaiser Permanente, honors Bernard J. Tyson, late chief executive officer and reform advocate